Bird, Dominique

Fatehi, Farhad

Gray, Len

Karunanithi, Mohan

Menon, Anish

Russell, Anthony

University of Queensland eSpace

Page 41 
Mobile Diabetes Management System for Insulin Dose Adjustment in Type 2 Diabetes for 
Specialist Outreach and Diabetes Telehealth Service (REMODEL-IDA): A Pilot 
Randomised Controlled Trial 
Anish MENON1, Len GRAY2, Farhad FATEHI2, Dominique BIRD2, Mohan KARUNANITHI3, Anthony RUSSELL4 
1. Centre for Online Health, The University of Queensland, Queensland, Australia 
2. Centre for Health Services Research, The University of Queensland, Queensland, Australia 
3. CSIRO, Queensland, Australia 
4. Princess Alexandra Hospital, Metro South Health, Queensland, Australia 
Background 
Type 2 diabetes (T2DM) is a progressive disease that involves step-wise addition of multiple glucose lowering 
agents over time to achieve adequate individual glycaemic targets, with insulin being the most potent among them. 
Insulin initiation and/or titration for type 2 diabetes (T2DM) is a resource intensive process through an insulin dose 
adjustment (IDA) service led by a credentialed diabetes educator (CDE). There are limited resources in a regional 
and primary care setting.  
 
Hypothesis and Aim 
We hypothesize that eHealth offers an opportunity to transform the current model of IDA service delivery. The new 
model aims to improve glycaemic management, healthcare service delivery efficiency and the patients’ experience. 
 
Method 
We have developed a Mobile Diabetes Management System (MDMS) which has a patient front-end capability that 
enables patients to upload and view monitoring data and provides auto-generated text advice around their 
glycaemic management. It features a clinician portal to monitor and manage patients’ care. A two-arm pilot 
randomised controlled trial (RCT) will be conducted for 3 months with 44 type 2 diabetes participants, randomised 
at a 1:1 ratio to receive either the MDMS model of care (intervention) or routine care (control), in diabetes specialist 
outreach and telehealth clinics. These clinics serve disadvantaged and regional communities. The routine care arm 
will be followed up via telephone calls. The primary outcome is change in HbA1c, a marker of glycaemic 
management, at three months. Patient and healthcare provider satisfaction, and time required by health care 
providers in both arms will be collected.  
 
Conclusion 
This pilot study will inform retention, acceptability and glycaemic outcomes from people with T2DM, and clinicians 
to guide the conduct of a large pragmatic RCT across regional and remote Queensland, Australia. This has the 
potential to be integrated into routine diabetes care and build capacity for regional Australia. 
 
Correspondence: 
Anish Menon   
Centre for Online Health, The University of Queensland, Queensland, Australia 
anish.menon@uq.net.au 
 
 
 
 
 
 
 
 
 
 


Mobile diabetes management system for insulin dose adjustment in type 2 diabetes for specialist outreach and diabetes telehealth service (REMODEL-IDA): a pilot randomised controlled trial

https://espace.library.uq.edu.au/view/UQ:c944b83/UQc944b83_OA.pdf

Mobile diabetes management system for insulin dose adjustment in type 2 diabetes for specialist outreach and diabetes telehealth service (REMODEL-IDA): a pilot randomised controlled trial

Abstract

Similar works

Full text

Available Versions

University of Queensland eSpace